Journal article icon

Journal article

Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction. A report from the Irbesartan in Heart Failure with Preserved Ejection Fraction trial (I-Preserve)

Abstract:
Background—In patients with HF and preserved ejection fraction (HFpEF), little is known about the characteristics of and outcomes in those with and without diabetes. Methods—We examined clinical and echocardiographic characteristics and outcomes in the Irbesartan in Heart Failure with Preserved Ejection Fraction trial (I-Preserve), according to history of diabetes. Cox regression models were used to estimate hazard ratios (HR) for cardiovascular outcomes adj... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted Manuscript

Actions


Access Document


Files:
Publisher copy:
10.1161/CIRCULATIONAHA.116.024593

Authors


More by this author
Department:
Oxford, MSD, Nuffield Department of Population Health, Clinical Trial Service Unit
Role:
Author
Expand authors...
Publisher:
American Heart Association Publisher's website
Journal:
Circulation Journal website
Volume:
135
Issue:
8
Pages:
724-735
Publication date:
2017-01-01
Acceptance date:
2016-12-09
DOI:
EISSN:
1524-4539
ISSN:
0009-7322
Pubs id:
pubs:666770
URN:
uri:7ca6fd48-a270-4846-a795-9715638c194b
UUID:
uuid:7ca6fd48-a270-4846-a795-9715638c194b
Local pid:
pubs:666770
Paper number:
8

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP